Non-renal indications for continuous renal replacement therapy.

While there is clear support for the use of continuous renal replacement therapy (CRRT) in critically ill acute renal failure patients, there are other illnesses without renal involvement where CRRT might be of value. These include sepsis and other inflammatory syndromes such as acute respiratory distress syndrome (ARDS) and cardiopulmonary bypass where removal of inflammatory mediators by hemofiltration is hypothesized to improve outcome. Adsorption appears to be the predominant mechanism of mediator elimination. However, the observed hemodynamic improvement can, at least partially, be attributed to a reduction of body temperature or to fluid removal, and the evidence for a clinically important removal of proinflammatory cytokines remains limited. Continuous and therefore smooth fluid removal may improve organ function in ARDS, after surgery with cardiopulmonary bypass, and in patients with refractory congestive heart failure. Continuous removal of endogenous toxins, eventually combined with intermittent hemodialysis, is probably beneficial in inborn errors of metabolism, severe lactic acidosis, or tumor lysis syndrome.

[1]  J. De Sutter,et al.  Cytokine removal during continuous hemofiltration in septic patients. , 1999, Journal of the American Society of Nephrology : JASN.

[2]  E. Mayatepek,et al.  Dialysis in neonates with inborn errors of metabolism. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  R. Prokesch,et al.  The spectrum of acute renal failure in tumour lysis syndrome. , 1999, Nephrology, Dialysis and Transplantation.

[4]  John P. Johnson,et al.  Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. , 1998, Critical care medicine.

[5]  G. Lonnemann,et al.  Transfer of endogenous pyrogens across artificial membranes? , 1998, Kidney international. Supplement.

[6]  M. Schetz Classical and alternative indications for continuous renal replacement therapy. , 1998, Kidney international. Supplement.

[7]  R. W. Pryor,et al.  Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. , 1998, Critical care medicine.

[8]  L. Forni,et al.  Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. , 1998, QJM : monthly journal of the Association of Physicians.

[9]  M. Turrentine,et al.  Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. , 1998, The Journal of thoracic and cardiovascular surgery.

[10]  M. Davies,et al.  Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. , 1998, The Journal of thoracic and cardiovascular surgery.

[11]  L. Forni,et al.  Lactate intolerance with continuous venovenous haemofiltration: the role of bicarbonate-buffered haemofiltration , 1998 .

[12]  A. Ambrós,et al.  Influence of continuous hemofiltration on the hemodynamics of trauma patients. , 1997, Surgery.

[13]  J. Riera,et al.  Cytokines clearance during venovenous hemofiltration in the trauma patient , 1997 .

[14]  B. Bastani,et al.  Significant myoglobin removal during continuous veno-venous haemofiltration using F80 membrane. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  H. Rinka,et al.  Blood purification for crush syndrome. , 1997, Renal failure.

[16]  I. Tzanakis,et al.  Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  J. Peters,et al.  Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNFα plasma concentrations , 1997, Intensive Care Medicine.

[18]  K. Leunissen,et al.  Critical role of the extracorporeal blood temperature in the hemodynamic response during hemofiltration. , 1997, Journal of the American Society of Nephrology : JASN.

[19]  H. Bruining,et al.  Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. , 1997, Renal failure.

[20]  A. Discipio,et al.  Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine intra-abdominal sepsis. , 1997, American journal of surgery.

[21]  S. Morgera,et al.  Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration , 1997, Intensive Care Medicine.

[22]  K. Klouche,et al.  Slow isolated ultrafiltration for the treatment of congestive heart failure , 1996 .

[23]  P. Vouhé,et al.  High-volume, Zero-balanced Hemofiltration to Reduce Delayed Inflammatory Response to Cardiopulmonary Bypass in Children , 1996, Anesthesiology.

[24]  D. Nicolau,et al.  Evaluation of Myoglobin Clearance during Continuous Hemofiltration in a Swine Model of Acute Renal Failure , 1996, The International journal of artificial organs.

[25]  R. Bone,et al.  Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.

[26]  L. Gentilello,et al.  Hypothermia induced by continuous arteriovenous hemofiltration as a treatment for adult respiratory distress syndrome: a case report. , 1996, The Journal of trauma.

[27]  K. Soma,et al.  Removal of circulating cytokines by continuous haemofiltration in patients with systemic inflammatory response syndrome or multiple organ dysfunction syndrome , 1996, British Journal of Surgery.

[28]  D. Inthorn,et al.  Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. , 1995, Contributions to nephrology.

[29]  T. Philipp,et al.  The influence of continuous hemofiltration on cytokine elimination and the cardiovascular stability in the early phase of sepsis. , 1995, Contributions to nephrology.

[30]  D. Bose,et al.  Effect of Continuous Arteriovenous Hemofiltration Combined with Systemic Vasopressor Therapy on Depressed Left Ventricular Contractility and Tissue Oxygen Delivery in Canine Escherichia coli Sepsis , 1995, Anesthesiology.

[31]  G. Bottoms,et al.  Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. , 1995 .

[32]  C. Natanson,et al.  Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. , 1995, Journal of the American College of Surgeons.

[33]  M. Guazzi,et al.  Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. , 1994, British heart journal.

[34]  S. Heidemann,et al.  Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. , 1994, Circulatory shock.

[35]  W. Greeley,et al.  Hemofiltration during Cardiopulmonary Bypass in Pediatric Cardiac Surgery: Effects on Hemostasis, Cytokines, and Complement Components , 1994, Anesthesiology.

[36]  S. Goldfarb,et al.  Proinflammatory cytokines and hemofiltration membranes. , 1994, Journal of the American Society of Nephrology : JASN.

[37]  M. Nabuurs,et al.  HIGH VOLUME HEMOFILTRATION IMPROVES HEMODYNAMICS AND SURVIVAL OF PIGS EXPOSED TO GUT ISCHEMIA AND REPERFUSION , 1994, Shock.

[38]  V. Pichette,et al.  High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  M. Guazzi,et al.  Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. , 1994, The American journal of medicine.

[40]  P. Toft,et al.  Cytokines in Plasma and Ultrafiltrate during Continuous Arteriovenous Haemofiltration , 1993, Anaesthesia and intensive care.

[41]  M. Elliott,et al.  Ultrafiltration and modified ultrafiltration in pediatric open heart operations. , 1993, The Annals of thoracic surgery.

[42]  R. W. Pryor,et al.  Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus‐induced septicemia in immature swine , 1993, Critical care medicine.

[43]  J. Schifferli,et al.  Adsorption of complement factor D by polyacrylonitrile dialysis membranes. , 1993, Kidney international.

[44]  R. Bellomo,et al.  Continuous veno‐venous hemofiltration with dialysis removes cytokines from the circulation of septic patients , 1993, Critical care medicine.

[45]  F. Barbaresi,et al.  Intermittent venovenous hemofiltration as a chronic treatment for refractory and intractable heart failure. , 1992, ASAIO journal.

[46]  J. Wetzels,et al.  Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. , 1992, Lymphokine and cytokine research.

[47]  H. Reines,et al.  Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation , 1992, Critical care medicine.

[48]  R. Bellomo,et al.  Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. , 1991, ASAIO transactions.

[49]  D. Howells,et al.  Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism. , 1991, The Journal of pediatrics.

[50]  M. Nagaki,et al.  Removal of Endotoxin and Cytokines by Adsorbents and the Effect of Plasma Protein Binding , 1991, The International journal of artificial organs.

[51]  W. Sperl,et al.  Continuous arteriovenous haemofiltration in hyperammonaemia of newborn babies , 1990, The Lancet.

[52]  M. Guazzi,et al.  Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. , 1990, The American journal of cardiology.

[53]  D. Bose,et al.  hemofiltration reverses left ventricular dysfunction during sepsis in dogs. , 1990, Anesthesiology.

[54]  H. Humphrey,et al.  Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. , 1990, Chest.

[55]  R. Ponikvar,et al.  Anaphylatoxins C3a and C5a Adsorption on Acrylonitrile Membrane of Hollow-fiber and Plate Dialyzer – an in Vivo Study , 1990, The International journal of artificial organs.

[56]  M. Wendt,et al.  Hemofiltration in Myoglobinuric Acute Renal Failure , 1990, The International journal of artificial organs.

[57]  C. Cipolla,et al.  Hemofiltration as short-term treatment for refractory congestive heart failure. , 1987, The American journal of medicine.

[58]  A. Cheung,et al.  Compartmental distribution of complement activation products in artificial kidneys. , 1986, Kidney international.

[59]  R. Bellomo,et al.  Preliminary experience with high-volume hemofiltration in human septic shock. , 1998, Kidney international. Supplement.

[60]  E. V. Bommel Should continuous renal replacement therapy be used for ‘non-renal’ indications in critically ill patients with shock? , 1997 .

[61]  M. Schetz Evidence-based analysis of the role of hemofiltration in sepsis and multiorgan dysfunction syndrome , 1997 .

[62]  C. Ichai,et al.  Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. , 1997, Critical care medicine.

[63]  J. Chevrolet,et al.  Complement depletion during haemofiltration with polyacrilonitrile membranes. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[64]  H. Bruining,et al.  Cytokine Kinetics (TNF-α, IL-1β, IL-6) during Continuous Hemofiltration: A Laboratory and Clinical Study , 1995 .

[65]  R. Bellomo,et al.  Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. , 1995, Renal failure.

[66]  I. Marzi,et al.  Influence of venovenous hemofiltration on posttraumatic inflammation and hemodynamics. , 1995, Contributions to nephrology.

[67]  C. Ronco,et al.  Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. , 1995, Critical care medicine.

[68]  W. Banzhaf,et al.  Effect of continuous hemodiafiltration on IL-6, TNF-alpha, C3a, and TCC in patients with SIRS/septic shock using two different membranes. , 1995 .

[69]  C. Dinarello,et al.  Removal of Circulating Cytokines by Hemodialysis Membranes In Vitro , 1993 .

[70]  M. Guazzi,et al.  Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. , 1993, The American journal of medicine.

[71]  P. Fauchald,et al.  Hormonal changes in patients with severe chronic congestive heart failure treated by ultrafiltration. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[72]  F. Cosentino,et al.  Continuous arteriovenous hemofiltration in the adult respiratory distress syndrome. A randomized trial. , 1991, Contributions to nephrology.

[73]  M. Rudnick,et al.  Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis. , 1991, American journal of nephrology.

[74]  B. Schneeweiss,et al.  Influence of ultrafiltration/hemofiltration on extravascular lung water. , 1991, Contributions to nephrology.

[75]  P. J. Hilton,et al.  Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[76]  T. Balstad,et al.  Generation and removal of anaphylatoxins during hemofiltration with five different membranes. , 1988, Blood purification.

[77]  J. Hertel,et al.  Polyacrylonitrile complement activation attenuated by simultaneous ultrafiltration and adsorption. , 1987, Nephrology, Dialysis and Transplantation.

[78]  E. Barzilay,et al.  Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. , 1986, Resuscitation.